Article Text
PostScript
Letter
Reply to the letter by Dr Graham concerning ethical and interpretation issues with vonoprazan-containing H. pylori eradication therapy
Statistics from Altmetric.com
Footnotes
Contributors KM, YS, MS, NF, AN and MA wrote and approved the author's response to the Letter by Dr Graham.
Competing interests KM and MA are independent medical consultants providing expert advice to Takeda Pharmaceutical Company Ltd. YS, MS, NF and AN are employees of Takeda Pharmaceutical Company Ltd.
Provenance and peer review Not commissioned; internally peer reviewed.